A federal judge in Texas, in an unprecedented move, has ordered the U.S. Food and Drug Administration (FDA) to temporarily halt its approval of mifepristone, a drug used for abortion.
U.S. District Judge Matthew J. Kacsmaryk, a Trump appointee in Amarillo, Texas, signed an injunction directing the FDA to stay mifepristone’s approval, while the lawsuit that challenges the safety and approval of the drug continues.
Kacsmaryk said the FDA had ignored risks in approving the drug. “The Court does not second-guess FDA’s decision-making lightly,” reads the decision (pdf). “But here, FDA acquiesced on its legitimate safety concerns—in violation of its statutory duty—based on plainly unsound reasoning and studies that did not support its conclusions….
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta